Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:08 p.m.

    📋 PHATHOM PHARMACEUTICALS, INC. (PHAT) - Financial Results

    Filing Date: 2022-08-02

    Accepted: 2022-08-02 08:25:57

    Event Type: Financial Results

    Event Details:

    Phathom Pharmaceuticals Inc (PHAT) Reports Q3 2022 Financial Results Phathom Pharmaceuticals Inc (PHAT) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: $260 million
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 207392
      • expected in Q1 2023
      • targeting US launch in Q1 2023

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Loss From Operations 35.32K 83.27K $-47.95K -57.58%
    Other Income Expense Interest Income 13.00 119.00 $-106.00 -89.08%
    Other Income Expense Interest Expense 1.26K 8.43K $-7.17K -85.09%
    Net Loss Per Share 1.00 2.40 $-1.40 -58.33%
    Loss from Operations 35.32K 83.27K $-47.95K -57.58%
    Interest Income 13.00 119.00 $-106.00 -89.08%
    Interest Expense 1.26K 8.43K $-7.17K -85.09%
    Net Loss 36.55K 91.58K $-55.03K -60.09%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Phathom Pharmaceuticals Inc
    • CIK: 0001783183
    • Ticker Symbol: PHAT
    • Period End Date: 2022-08-02
    • Document Type: 8-K

Search

News categories